tiprankstipranks
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
US Market
ZVRA
Zevra Therapeutics
RESEARCH TOOLSreports

Zevra Therapeutics (ZVRA) Income Statement

1,051 Followers

Zevra Therapeutics Income Statement

Last quarter (Q4 2025), Zevra Therapeutics's total revenue was $34.13M, an increase of 183.36% from the same quarter last year. In Q4, Zevra Therapeutics's net income was $12.16M. See Zevra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 106.47M$ 23.61M$ 27.46M$ 10.16M$ 28.65M
Gross Profit
$ 89.99M$ 16.20M$ 24.52M$ 9.94M$ 26.59M
Operating Expenses
$ 94.22M$ 103.20M$ 74.12M$ 52.50M$ 18.86M
Depreciation and Amortization
$ 4.05M$ 6.39M$ 1.01M$ 944.00K$ 257.00K
EBITDA
$ 98.71M$ -76.40M$ -43.54M$ -25.53M$ -7.89M
Operating Income
$ -4.23M$ -87.00M$ -49.60M$ -42.56M$ 7.73M
Other Income/Expenses
$ 90.91M$ -3.14M$ 3.56M$ 15.76M$ -16.25M
Pretax Income
$ 86.68M$ -90.14M$ -46.05M$ -26.80M$ -8.52M
Net Income
$ 83.23M$ -105.51M$ -46.05M$ -26.77M$ -8.55M
Per Share Metrics
Basic EPS
$ 1.40$ -2.28$ -1.30$ -0.78$ -2.11
Diluted EPS
$ 1.35$ -2.28$ -1.30$ -0.78$ -2.11
Weighted Average Shares Outstanding
 55.31M 46.25M 35.45M 34.49M 29.77M
Weighted Average Shares Outstanding (Diluted)
 57.26M 46.25M 35.45M 34.49M 29.77M
Currency in USD

Zevra Therapeutics Earnings and Revenue History